Laura Chambre

511 citations
11 papers · 412 indexed · h-index 11
Topics
Silk-based biomaterials and applications (4 papers)Electrospun Nanofibers in Biomedical Applications (3 papers)Nanoplatforms for cancer theranostics (3 papers)

In The Last Decade

Laura Chambre

11 papers receiving 411 citations

Peers

Laura Chambre
Comparison fields: 5 of 66
  • Biomaterials 244
  • Biomedical Engineering 145
  • Molecular Biology 125
  • Pharmaceutical Science 78
  • Materials Chemistry 43
Replace Sumei Qin with:
Sumei Qin China
Melisa Samarikhalaj Canada
K. Vijaya Krishna India
David A. Castilla‐Casadiego United States
Aipeng Deng China
Jingli Ren China
Huinan Suo China
Joana Lopes Portugal
Tianxu Fang China
Sepideh Saghati Iran
Laura Chambre relative to Sumei Qin China Sumei Qin's profile →
Citations per field
00.5×5.7×
Sumei Qin · 1×
Citations per year

Countries citing papers authored by Laura Chambre

Since Specialization
Citations

This map shows the geographic impact of Laura Chambre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Chambre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Chambre more than expected).

Fields of papers citing papers by Laura Chambre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Chambre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Chambre. The network helps show where Laura Chambre may publish in the future.

Co-authorship network of co-authors of Laura Chambre

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Chambre. A scholar is included among the top collaborators of Laura Chambre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Chambre. Laura Chambre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 12
2 72
3 17
4 21
5 69
6 27
7 32
8 49
9 44
10 20
11 49

About Laura Chambre

Laura Chambre is a scholar working on Biomaterials, Pharmaceutical Science and Microbiology, having authored 11 papers that have together received 412 indexed citations. Recurring topics across this work include Silk-based biomaterials and applications (4 papers), Electrospun Nanofibers in Biomedical Applications (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (244 citations), Pharmaceutical Science (78 citations) and Molecular Medicine (31 citations). Laura Chambre has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include David L. Kaplan, Amitav Sanyal, Rana Sanyal, Burçin Yavuz, Rachael N. Parker, Zaira Martín‐Moldes, Jonathan A. Kluge, Aysun Degirmenci, Sabine Szunerits and Duygu Yılmaz Aydın. Their work appears in journals such as Advanced Drug Delivery Reviews, ACS Applied Materials & Interfaces and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026